{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:39:28Z","timestamp":1792643968866,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4022,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1538-7836.2011.04487.x","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T18:37:51Z","timestamp":1314815871000},"page":"2389-2396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Fondaparinux treatment of acute heparin\u2010induced thrombocytopenia confirmed by the serotonin\u2010release assay: a 30\u2010month, 16\u2010patient case series"],"prefix":"10.1016","volume":"9","author":[{"given":"T.E.","family":"WARKENTIN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"PAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.I.","family":"SHEPPARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"SCHULMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"SPYROPOULOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"EIKELBOOM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMp068309","article-title":"Drug\u2010induced immune\u2010mediated thrombocytopenia \u2013 from purpura to thrombosis","volume":"356","author":"Warkentin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1365-2141.2003.04363.x","article-title":"Biological and clinical features of low\u2010molecular\u2010weight heparin\u2010induced thrombocytopenia","volume":"121","author":"Gruel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0020","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1365-2141.1996.407945.x","article-title":"Pathogenicity of IgA and\/or IgM antibodies to heparin\u2013PF4 complexes in patients with heparin\u2010induced thrombocytopenia","volume":"92","author":"Amiral","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0025","first-page":"247","article-title":"Heparin\u2010associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4\u2013heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14\u2010year study of heparin\u2010induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2011.04487.x_bb0035","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin\u2010induced thrombocytopenia. American College of Chest Physicians evidence\u2010based clinical practice guidelines (8th edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0040","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1055\/s-0037-1616046","article-title":"Prospective, randomised open\u2010label comparison of danaparoid with dextran 70 in the treatment of heparin\u2010induced thrombocytopaenia with thrombosis. A clinical outcome study","volume":"86","author":"Chong","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.thromres.2005.04.011","article-title":"Results of a systematic evaluation of treatment outcomes for heparin\u2010induced thrombocytopenia in patients receiving danaparoid, ancrod, and\/or coumarin explain the rapid shift in clinical practice during the 1990s","volume":"117","author":"Lubenow","year":"2006","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0050","series-title":"Heparin\u2010induced Thrombocytopenia","first-page":"319","article-title":"Danaparoid for the treatment of heparin\u2010induced thrombocytopenia","author":"Chong","year":"2007"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0055","series-title":"Heparin\u2010induced Thrombocytopenia","first-page":"441","article-title":"Emerging anticoagulants and heparin\u2010induced thrombocytopenia: indirect and direct factor\u00a0Xa inhibitors and oral thrombin inhibitors","author":"Bradner","year":"2007"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1378\/chest.10-1599","article-title":"Prevalence and risk of pre\u2010existing heparin\u2010induced thrombocytopenia antibodies in patients with acute venous thromboembolism","volume":"140","author":"Warkentin","year":"2011","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/ehm.10.54","article-title":"Fondaparinux: does it cause HIT? can it treat HIT?","volume":"3","author":"Warkentin","year":"2010","journal-title":"Exp Rev Hematol"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0070","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1055\/s-0037-1616573","article-title":"Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux","volume":"93","author":"Kuo","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1160\/TH07-04-0252","article-title":"Fondaparinux for the treatment of patients with acute heparin\u2010induced thrombocytopenia","volume":"99","author":"Lobo","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1076029609347900","article-title":"Fondaparinux for the treatment of acute heparin\u2010induced thrombocytopenia: a single\u2010center experience","volume":"16","author":"Grouzi","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0085","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jtcvs.2008.11.032","article-title":"Treatment of heparin\u2010induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux","volume":"139","author":"Pappalardo","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0090","first-page":"148","article-title":"Laboratory diagnosis of immune heparin\u2010induced thrombocytopenia","volume":"2","author":"Warkentin","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin\u2010induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2141.1996.d01-1876.x","article-title":"The epitope specificity of heparin\u2010induced thrombocytopenia","volume":"95","author":"Horsewood","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0105","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","article-title":"Heparin\u2010induced thrombocytopenia: a prospective study on the incidence, platelet\u2010activating capacity and clinical significance of anti\u2010PF4\/heparin antibodies of the IgG, IgM, and IgA classes","volume":"5","author":"Greinacher","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0110","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non\u2010surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.22043","article-title":"Chills and limb pain following administration of low\u2010molecular\u2010weight heparin for treatment of acute venous thromboembolism","volume":"86","author":"Hillis","year":"2011","journal-title":"Am J Hematol"},{"issue":"Suppl. 5","key":"10.1111\/j.1538-7836.2011.04487.x_bb0120","first-page":"17","article-title":"Limitations of conventional treatment options for heparin\u2010induced thrombocytopenia","volume":"35","author":"Warkentin","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0037-1615601","article-title":"Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin","volume":"85","author":"Sheth","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0130","series-title":"Heparin\u2010induced Thrombocytopenia","first-page":"345","article-title":"Lepirudin for the treatment of heparin\u2010induced thrombocytopenia","author":"Greinacher","year":"2007"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin\u2010induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0140","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/j.1538-7836.2011.04489.x","article-title":"Fondaparinux in acute heparin\u2010induced thrombocytopenia: a case series","volume":"9","author":"Goldfarb","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04487.x_bb0145","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4\u2010dependent enzyme\u2010immunoassays","volume":"6","author":"Warkentin","year":"2008","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2011.04487.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622074608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622074608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2011.04487.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:54:15Z","timestamp":1761533655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622074608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1538783622074608"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04487.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717979510.793471293","asserted-by":"object"}]},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fondaparinux treatment of acute heparin\u2010induced thrombocytopenia confirmed by the serotonin\u2010release assay: a 30\u2010month, 16\u2010patient case series","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04487.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}